Alexander Gebauer

Alexander Gebauer has a diverse work experience in the pharmaceutical industry. Alexander is currently the CEO of Secarna Pharmaceuticals since December 2020. Prior to that, they co-founded and served as the Executive Chairman of Galimedix Inc. starting from June 2018. Alexander also held the position of Chairman of the Board of Directors at Omeicos Ophthalmics Inc. from March 2018 to November 2020. Alexander has also served as the Managing Director of OMEICOS Therapeutics GmbH from December 2017 to November 2020. Alexander was a member of the Board of Directors at Vaccentis AG from July 2017 to July 2019. Alexander gained experience in research and development roles at SUN PHARMA as the President and Head of R&D from March 2015 to April 2016, and as the President of Ranbaxy Laboratories Ltd. from July 2014 to March 2015. Alexander has also held various positions at Merz Pharmaceuticals, including CSO and Head Global R&D from July 2006 to June 2014, and VP of Global Clinical R&D from May 2005 to June 2006. Prior to that, they worked as the VP of Global Project Direction at sanofi-aventis and as the Coordinator for LO (early development) at Aventis.

Alexander Gebauer obtained their Doctor of Medicine (MD) and PhD degrees from Johannes Gutenberg University Mainz from 1982 to 1988, specializing in the field of Medizin. Following this, they pursued a Bachelor of Applied Science (BASc) degree in Informatics at CBI, Wiesbaden, from 1988 to 1989.